MGI Releases Holistic Solution for One Million Genomes
January 13, 2020
SAN FRANCISCO, CA – MGI, one of the world’s leading manufacturers of DNA sequencing instruments, today launched its One Million Genomes Total Solution, a full-process software and hardware solution for one million genome projects. The integrated system will promote standardization and effectively solve the pain points in the industry and accelerate the arrival of the [...]
January 13, 2020
CAMBRIDGE, UK, and LEUVEN, Belgium – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has partnered with imec, a world-leading research and innovation hub active in the fields of nanoelectronics and digital technologies, to increase production of Evonetix’s proprietary microelectromechanical systems (MEMS)-based silicon chips, [...]
ALLERGAN AND AVITIDE EXPAND PARTNERSHIP TO DEVELOP CUSTOM AFFINITY CHROMATOGRAPHY TECHNOLOGIES
January 13, 2020
Lebanon, New Hampshire – Avitide Inc., the industry leader in the discovery and development of custom affinity purification resins, announce a partnership expansion with Allergan. Under the terms of the agreement, Avitide will use its proprietary affinity chromatography discovery, development, and supply platform for programs defined by Allergan. “The expansion of our partnership with Allergan [...]
Illumina and Roche Partner to Broaden Patient Access to Genomic Testing
January 13, 2020
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Roche, a global pioneer in pharmaceuticals and diagnostics, today announced a 15-year, non-exclusive collaboration agreement to broaden the adoption of distributable next-generation sequencing-based (NGS) testing in oncology. As the understanding of genomic drivers of cancer evolves, NGS has [...]
Horizon Discovery signs collaboration and license agreement with Mammoth Biosciences
January 13, 2020
Aims to develop the next generation of engineered CHO cell lines, to improve production of biotherapeutics Bioproduction is a key business unit within Horizon, this agreement underlines strategy to focus on core markets Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader in the application of gene editing and [...]
January 13, 2020
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and partnership announcements that further the company’s commitment to unlocking the power of the genome. The NextSeq 2000 Sequencing System — The latest NGS system from Illumina [...]
January 13, 2020
First Company Developing a KRAS(G12C) Inhibitor to Announce Multi-Platform Companion Diagnostics Collaborations With Guardant Health and QIAGEN Will Develop Blood- and Tissue-Based Companion Diagnostics For Investigational KRAS(G12C) Inhibitor AMG 510 KRAS G12C is Present in 13% of Non-Small Cell Lung Cancers With no Approved Targeted Treatments THOUSAND OAKS, Calif. — Amgen (NASDAQ: AMGN) today announced [...]
Statement: MGI is committed to protecting its intellectual property assets on a global scale
January 11, 2020
MGI makes the following statement in response to Illumina’s patent litigation in the UK and Sweden: We believe these claims have no merit and are typical Illumina tactics intended to maintain a monopolistic market position and prevent choice from being offered to customers. We intend to vigorously defend ourselves, as we have in other jurisdictions. [...]
QIAGEN celebrates surpassing 2,500 cumulative placements of QIAsymphony
January 10, 2020
• Milestone instrument placed with Cenata GmbH in Germany • More than 30 diagnostic assays, including eight FDA approved tests available for the system • Launch of new PowerFecal Pro Kit automating microbiome sample preparation Hilden, Germany, and Germantown, Maryland, January 9, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,500th [...]
Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom
January 10, 2020
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed two additional patent infringement suits relating to BGI’s sequencing products, including the DNBSeq-400 (also known as MGISeq-2000), DNBSeq-T7, and related chemistry reagents. The first complaint was filed against MGI Tech Co., Ltd. and Latvia MGI Tech SIA in the High Court of [...]
